The pharmaceutical community is excited by retatrutide, a innovative dual GIP and GLP-1 target that’s showing significant results in clinical research. This medication works by imitating natural hormones to impact appetite and increase feelings of satisfaction , ultimately contributing to noticeable fat loss . While still under review and not yet